The gene therapy market is projected to be growing at a CAGR of 30%- Roots Analysis'

Your avatar
EL
Ella

Given their potential to treat rare, inherited diseases, as well as those previously deemed incurable, the field of gene therapy has gained significant traction in the last few years

 

Roots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (4th Edition), 2020-2030”.

 

The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral therapies, immunotherapies and gene editing therapies. The study also features an elaborate discussion on the future potential of this evolving market. In addition to other elements, the study includes:

A detailed review of the overall market landscape of gene therapies and gene editing therapies, including information on phase of development of pipeline candidates, key therapeutic areas, target disease indication(s), type of vector used, type of gene, type of modification, type of gene therapy, route of administration and special drug designation(s) awarded (if any).

A detailed review of the players engaged in the development of gene therapies.

An elaborate discussion on the various types of viral and non-viral vectors.

A discussion on the regulatory landscape related to gene therapies across various geographies, namely North America, Europe and Asia-Pacific.

Detailed profiles of marketed and late stage (phase II/III and above) gene therapies.

An elaborate discussion on the various commercialization strategies that can be adopted by drug developers across different stages of therapy development.

A review of the various emerging technologies and therapy development platforms that are being used to design and manufacture gene therapies.

An in-depth analysis of various patents that have been filed / granted related to gene therapies and gene editing therapies, since 2016.

A detailed analysis of the various mergers and acquisitions that have taken place within this domain, during the period 2015-2020.

An analysis of the investments made at various stages of development in companies that are focused in this area, between 2015-2020.

A detailed geographical clinical trial analysis of completed, ongoing and planned studies of numerous gene therapies.

An analysis of the various factors that are likely to influence the pricing of gene therapies.

An analysis of the big biopharma players engaged in this domain.

An informed estimate of the annual demand for gene therapies.

A case study on the prevalent and emerging trends related to vector manufacturing.

A discussion on the various operating models adopted by gene therapy developers for supply chain management.

A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

Therapeutic Approach 

Gene augmentation

Oncolytic therapy

Immunotherapy

Others

Type of gene therapy

Ex vivo

In vivo

Type of vector used

Adeno associated virus

Adenovirus

Herpes simplex virus

Lentivirus

Plasmid DNA

Retrovirus

Others

Key therapeutic areas

Autoimmune disorders

Cardiovascular diseases

Dermatological disorders

Genetic disorders

Hematological disorders

Metabolic disorders

Muscle-related diseases

Oncological disorders

Ophthalmic diseases

Others

Route of administration

Intraarticular

Intracerebellar

Intradermal

Intramuscular

Intratumoral

Intravenous

Intravesical

Intravitreal

Subretinal

Others

Key geographical regions 

North America

Europe

Asia-Pacific

 

Key companies covered in the report

Abeona Therapeutics

Advantagene

Biogen

bluebird bio

Castle Creek Biosciences

CG Oncology

FerGene

Freeline Therapeutics

Gradalis

Helixmith

Inovio Pharmaceuticals

Kolon TissueGene

Krystal Biotech

Lysogene

Neurophth Therapeutics

OncoSec Immunotherapies

Orchard Therapeutics

Pfizer

Sangamo Therapeutics

Spark Therapeutics

uniQure Biopharma

VBL Therapeutics

 

For more information, please click on the following link:

https://www.rootsanalysis.com/reports/view_document/gene-therapies-market/268.html

 

Other Recent Offerings

Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (4th Edition), 2021-2030

Global T-Cell (CAR-T, TCR, and TIL) Therapies Market (5th Edition), 2020-2030

Oncolytic Virus Therapy Market: Pipeline Review, Developer Landscape and Competitive Insights, 2020-2030

 

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

 

Contact Information

Roots Analysis Private Limited

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com

 

Keep discovering on Mamby:

If you liked this post, you may also be interested in...
O
Information Work with us Contact Terms and Conditions FAQs
© 2021, Mamby Investments